首页 >
法规速递
-
Document: European medicines agencies network strategy (EMANS) to 2025: Final report-2026/3/31
2026-04-01查看详情 > -
Page: Pharmaceutical industry-2026/3/31
2026-04-01查看详情 > -
Page: Classification of changes: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Changing the labelling and package leaflet (Article 61(3) notifications)-2026/3/27
2026-03-30查看详情 > -
Document: Timetable: Initial (full) marketing authorisation application assessment-2026/3/27
2026-03-30查看详情 > -
Document: EU implementation strategy of ICH E2D(R1) Guideline - Post-approval safety data: Definitions and standards for management and reporting of individual case safety reports-2026/3/27
2026-03-30查看详情 > -
Page: Transfer of marketing authorisation: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Submitting results of paediatric studies-2026/3/27
2026-03-30查看详情 > -
Page: Periodic safety update reports (PSURs)-2026/3/27
2026-03-30查看详情 > -
Page: Data quality framework for medicines regulation-2026/3/27
2026-03-30查看详情 >
